Actymo harnesses a state-of-the-art 100,000 sq ft facility in Saykha, Gujarat, using advanced clean-room and reactor technologies to produce APIs across cardiovascular, respiratory, neurological, anti-infective, and specialty segments. Their versatile capabilities—ranging from hydrogenation and cryogenic reactions to high-temperature and acid-resistant synthesis—are backed by ISO 9001 and GMP certifications, an 85%-complete USFDA compliance pathway, and a relentless focus on quality, reliability, and regulatory readiness.